MSEGX | RGAFX | MSEGX / RGAFX | |
Total Expense Ratio | 0.82 | 0.34 | 241% |
Annual Report Gross Expense Ratio | 0.82 | 0.34 | 241% |
Fund Existence | 29 years | 23 years | - |
Gain YTD | -1.735 | -2.338 | 74% |
Front Load | 5% | N/A | - |
Min. Initial Investment | 1000 | 250 | 400% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 3.77B | 284B | 1% |
Annual Yield % from dividends | 0.43 | 0.65 | 66% |
Returns for 1 year | 41.82 | 3.96 | 1,056% |
Returns for 3 years | 42.96 | 35.06 | 123% |
Returns for 5 years | -11.27 | 46.01 | -24% |
Returns for 10 years | 20.27 | 63.54 | 32% |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
BIAWX | 50.05 | N/A | N/A |
Brown Advisory Sustainable Growth Inv | |||
VNVNX | 22.15 | N/A | N/A |
Natixis Vaughan Nelson Mid Cap N | |||
FBTDX | 96.52 | N/A | N/A |
Franklin Biotechnology Discovery C | |||
LCFLX | 12.88 | N/A | N/A |
Lord Abbett Focused Large Cap Value C | |||
CDWEX | 11.44 | -0.02 | -0.17% |
American Funds Dvlpg Wld Gr&Inc 529E |